Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 45-51 , January 2010

Sarcomas Across the Age Spectrum

  • Suzanne L. Wolden, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Suzanne L. Wolden, MD, Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021
    • ,
  • Kaled M. Alektiar, MD

References 

  1. Gurney J, Young J, Roffers S, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999;NIH Pub. No. 99-4649
  2. Turc-Carel C, Lizard-Nacol S, Justrabo E, et al. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet. 1986;19:361–362
  3. Crist WM, Anderson JR, Meza JL, et al. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–3102
  4. Lawrence W, Hays DM, Heyn R, et al. Lymphatic metastases with childhood rhabdomyosarcoma (A report from the Intergroup Rhabdomyosarcoma Study). Cancer. 1987;60:910–915
  5. Donaldson SS, Meza J, Breneman JC, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG. Int J Radiat Oncol Biol Phys. 2001;51:718–728
  6. Wolden SL, Anderson JR, Crist WM, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol. 1999;17:3468–3475
  7. Bolling T, Schuck A, Paulussen M, et al. Whole lung irradiation in patients with exclusively pulmonary metastases of Ewing tumors (Toxicity analysis and treatment results of the EICESS-92 trial). Strahlenther Onkol. 2008;184:193–197
  8. Donaldson SS, Anderson JR. Rhabdomyosarcoma: Many similarities, a few philosophical differences. J Clin Oncol. 2005;23:2586–2587
  9. Klem ML, Grewal RK, Wexler LH, et al. PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol. 2007;29:9–14
  10. Wolden SL, Wexler LH, Kraus DH, et al. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2005;61:1432–1438
  11. Yock TI, Krailo M, Fryer CJ, et al. Local control in pelvic Ewing sarcoma: Analysis from INT-0091—A report from the Children's Oncology Group. J Clin Oncol. 2006;24:3838–3843
  12. Sultan I, Qaddoumi I, Yaser S, et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol. 2009;27:3391–3397
  13. Kushner BH, Hajdu SI, Gulati SC, et al. Extracranial primitive neuroectodermal tumors (The Memorial Sloan-Kettering Cancer Center experience). Cancer. 1991;67:1825–1829
  14. Parkin DM, Stiller CA, Nectoux J, et al. International variations in the incidence of childhood bone tumours. Int J Cancer. 1993;53:371–376
  15. Sreekantaiah C, Ladanyi M, Rodriguez E, et al. Chromosomal aberrations in soft tissue tumors (Relevance to diagnosis, classification, and molecular mechanisms). Am J Pathol. 1994;144:1121–1134
  16. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701
  17. Navid F, Santana VM, Billups CA, et al. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: The St. Jude Children's Research Hospital experience. Cancer. 2006;106:1846–1856
  18. Schuck A, Ahrens S, Paulussen M, et al. Local therapy in localized Ewing tumors: Results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys. 2003;55:168–177
  19. Krasin MJ, Rodriguez-Galindo C, Billups CA, et al. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 2004;60:830–838
  20. La TH, Meyers PA, Wexler LH, et al. Radiation therapy for Ewing's sarcoma: Results from Memorial Sloan-Kettering in the modern era. Int J Radiat Oncol Biol Phys. 2006;64:544–550
  21. Henderson TO, Whitton J, Stovall M, et al. Secondary sarcomas in childhood cancer survivors: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2007;9:300–308
  22. Kuttesch JF, Wexler LH, Marcus RB, et al. Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol. 1996;14:2818–2825
  23. Siegel RD, Ryan LM, Antman KH, et al. Adults with Ewing's sarcoma (An analysis of 16 patients at the Dana-Farber Cancer Institute). Am J Clin Oncol. 1988;11:614–617
  24. Trassard M, Le Doussal V, Hacene K, et al. Prognostic factors in localized primary synovial sarcoma: A multicenter study of 128 adult patients. J Clin Oncol. 2001;19:525–534
  25. Lewis JJ, Antonescu CR, Leung DH, et al. Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18:2087–2094
  26. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: A multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62:135–140
  27. Canter RJ, Qin LX, Maki RG, et al. A synovial sarcoma-specific preoperative nomogram supports a survival benefit to ifosfamide-based chemotherapy and improves risk stratification for patients. Clin Cancer Res. 2008;14:8191–8197
  28. Italiano A, Penel N, Robin YM, et al. Neoadjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: A study of the French Sarcoma Group. Ann Oncol. 2009;20:425–430
  29. Palmerini E, Staals EL, Alberghini M, et al. Synovial sarcoma: Retrospective analysis of 250 patients treated at a single institution. Cancer. 2009;115:2988–2998
  30. Guadagnolo BA, Zagars GK, Ballo MT, et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007;69:1173–1180
  31. Eilber FC, Brennan MF, Eilber FR, et al. Chemotherapy is associated with improved survival in adult patients with primary extremity synovial sarcoma. Ann Surg. 2007;246:105–113
  32. Sultan I, Rodriguez-Galindo C, Saab R, et al. Comparing children and adults with synovial sarcoma in the SEER program 1983 to 2005: An analysis of 1268 patients. Cancer. 2009;115:3537–3547
  33. Dalal KM, Antonescu CR, Singer S, et al. Diagnosis and management of lipomatous tumors. J Surg Oncol. 2008;97:298–313
  34. Schwab JH, Boland P, Guo T, et al. Skeletal metastases in myxoid liposarcoma: An unusual pattern of distant spread. Ann Surg Oncol. 2007;14:1507–1514
  35. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–391
  36. Singer S, Socci ND, Ambrosini G, et al. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma. Cancer Res. 2007;67:6626–6636
  37. Kooby DA, Antonescu CR, Brennan MF, et al. Atypical lipomatous tumor/well-differentiated liposarcoma of the extremity and trunk wall: Importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004;11:78–84
  38. Cahlon O, Brennan MF, Jia X, et al. A nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation. Proceedings of the American Society for Therapeutic Radiology and Oncology 50th Annual Meeting, Boston, MA Int J Radiat Oncol Biol Phys. 2008;72:S107
  39. Zagars GK, Goswitz MS, Pollack A, et al. Liposarcoma: outcome and prognostic factors following conservation surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1996;36:311–319
  40. Chung PW, Deheshi BM, Ferguson PC, et al. Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: A comparison with other soft tissue sarcomas. Cancer. 2009;115:3254–3261
  41. Eilber FC, Eilber FR, Eckardt J, et al. The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma. Ann Surg. 2004;240:686–695discussion 695-687

PII: S1053-4296(09)00064-2

doi: 10.1016/j.semradonc.2009.09.003

Seminars in Radiation Oncology
Volume 20, Issue 1 , Pages 45-51 , January 2010

Article Tools

* Image Usage & Resolution